HIV/AIDS
Research from G. Morsica and co-authors yields new data on HIV/AIDS
Published in AIDS Weekly, September 14th, 2009
In this recently published study, investigators in Milan, Italy conducted a study "To investigate the reciprocal inhibitory effects of hepatitis B virus (HBV)/hepatitis C virus (HCV)/hepatitis D virus (HDV) infections in naive and previously antiretroviral-experienced HIV-positive patients. This retrospective Study involved 72 consecutive patients of the Italian Cohort Naive Antiretroviral cohort: 21 coinfected with HBV/HCV (group IBC), 18 infected with HBV (group 2B), and 33 infected with HCV (group 3C)."
"Viral interference between HBV and HCV was assessed by means of the qualitative detection, quantification, and genotyping of each virus; HDV infection was assessed...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2009-09-14)
More Articles from AIDS Weekly
- BioMed Central
Urine LAM-ELISA poor at diagnosing TB - Johns Hopkins Medical Institutions
HIV subtype linked to increased likelihood for dementia - University of Washington
Counting duplicated genome segments now possible - Biotechnology Business
Reports outline biotechnology business study results from Amgen, Inc. - Chlamydia
Research on chlamydia discussed by M.J. Mimiaga and co-researchers - Cytomegalovirus
Data on cytomegalovirus discussed by R. Richter and colleagues - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
